Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Apr 14, 2021 5:14pm
190 Views
Post# 32995891

RE:RE:Interview with Tripp posted today

RE:RE:Interview with Tripp posted today
WizzyYR0 wrote: So Aristotle will only be sold through a doctor and wont be coming through the mail any time soon (especially with no FDA creds). There is no way they will penetrate the market successfully trying to sell an experiemental 1500$ cancer test with no marketing lol. Tripp says nothing new. All underhand T-Ball kinder garden questions for him agian. All vague answers. Same old "massive opportunity" talk for 4 years and running. Not impressive at all, in fact it's hard to watch him do this very old "song and dance" routine agian. 

These constructed mini interviews and rehearsed answers Tripp reads off his little cheat sheets is nausiating and hard to listen to. HE NEVER SAYS ANYTHING. He only does this to pretend to communicate with shareholders lol. He never speaks from the hearts or says anything new, just goes over his 2-3 talking points which are always extremely vague and old ideas. 

Most unispiring person I have ever heard talk. 



Try taping yourself some time and listen to that.....you will then have a more uninspiring person ............
<< Previous
Bullboard Posts
Next >>